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Abstract
Background: There are currently no purification methods capable of producing the large amounts of fish
rhabdoviral glycoprotein G (gpG) required for diagnosis and immunisation purposes or for studying structure and
molecular mechanisms of action of this molecule (ie. pH-dependent membrane fusion). As a result of the
unavailability of large amounts of the gpG from viral haemorrhagic septicaemia rhabdovirus (VHSV), one of the most
dangerous viruses affecting cultured salmonid species, research interests in this field are severely hampered. Previous
purification methods to obtain recombinant gpG from VHSV in E. coli, yeast and baculovirus grown in insect cells
have not produced soluble conformations or acceptable yields. The development of large-scale purification methods
for gpGs will also further research into other fish rhabdoviruses, such as infectious haematopoietic necrosis virus
(IHNV), spring carp viremia virus (SVCV), hirame rhabdovirus (HIRRV) and snakehead rhabdovirus (SHRV).
Findings: Here we designed a method to produce milligram amounts of soluble VHSV gpG. Only the
transmembrane and carboxy terminal-deleted (amino acid 21 to 465) gpG was efficiently expressed in insect larvae.
Recognition of G21-465 by ß-mercaptoethanol-dependent neutralizing monoclonal antibodies (N-MAbs) and pH-
dependent recognition by sera from VHSV-hyperimmunized or VHSV-infected rainbow trout (Oncorhynchus mykiss)
was demonstrated.
Conclusions: Given that the purified G21-465 conserved some of its most important properties, this method might
be suitable for the large-scale production of fish rhabdoviral gpGs for use in diagnosis, fusion and antigenicity
studies.
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Background
Membrane glycoproteins (gpGs) are highly relevant in
rhabdoviral infections [1]. Consequently, considerable
effort has been devoted to the structural and functional
analysis of these molecules [2,3]. However, large-scale
purification methods for fish gpGs have not been devel-
oped to date [4]. More concretely, production and puri-
fication techniques to obtain fish rhabdoviral gpGs in
milligram amounts for either immunisation or diagnosis,
as well as for studying their structure/functionality (ie.:
fusion) are required. In this regard, research into viral
haemorrhagic septicaemia rhabdovirus (VHSV), one of
the rhabdoviruses affecting aquacultured salmon and
trout species [5], is severely hindered by the lack of a
system with the capacity to produce sufficient amounts
of the gpG. Thus, the development of new tools for
detecting gpG-induced antibodies (Abs) to follow up
DNA vaccinations, the estimation of anti-gpG Abs in
survivors to control asymptomatic carrier fish move-
ments, and the study of the relevance of their lineal/
conformational epitopes in the protection of DNA vac-
cines, among others, would be facilitated by techniques
able to produce milligram amounts of purified gpG.
However, previous attempts to purify gpG using affinity
chromatography with immobilized monoclonal Abs
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from yeast [8-10] have met with only partial success.
Although these approaches gave a highly purified form
of the gpG, the yield was low and the isolated protein
showed a strong tendency to precipitate out of solution.
Furthermore, injection of fish with recombinant rhabdo-
viral gpGs produced in E. coli [11,12], yeast [11] or
baculovirus grown in insect cells [13] did not induce
satisfactory immune responses. This finding was attribu-
ted mostly to the precipitable conformations of these
molecules at physiological pH.
Although the gpG of fish rhabdoviruses has been
obtained in small amounts in insect cell cultures and
insect larvae by infection with recombinant baculo-
viruses [13-17], neither the large-scale production of
insect-produced VHSV gpG nor its antigenic properties
have been reported yet.
Here we used insect larvae to produce milligram
amounts of VHSV gpG in soluble form and in a confor-
mation as close as possible to its native structure. After
several attempts, VHSV gpG using a transmembrane and
carboxy terminal-deleted (amino acid 21 to 465) gpG
sequence (G21-465) was the only sequence of this protein
that we succeeded in expressing in large amounts. We
show here that G21-465 is recognized by conformation-
dependent (ß-mercaptoethanol-dependent) neutralizing
monoclonal antibodies (N-MAbs) and by sera from
VHSV-immunized trout in a pH-dependent manner. On
the basis of our findings, we propose that given that
recombinant G21-465 conserved some of its native prop-
erties and conformations, this purification procedure
might serve to produce sufficient fish rhabdoviral gpGs for
diagnosis, fusion and antigenicity studies.
Findings
Hypothesis
Recombinant VHSV gpG can be obtained in soluble milli-
gram amounts using baculoviruses grown in insect larvae.
This recombinant form binds to ß-mercaptoethanol-
dependent neutralizing-monoclonal antibodies (N-MAbs)
and shows pH-dependent conformational changes.
Methods
The construction and use of plasmid pMCV1.4-G coding
for the gpG (G1-507) of viral haemorrhagic septicemia
(VHSV) strain VHSV-0771, isolated in France from rain-
bow trout (Oncorhynchus mykiss) [18], was previously
described [19,20]. The DNA sequences corresponding to
G21-507 and G21-465 without their VHSV signal
sequence were amplified by PCR. The pMCV1.4-G plas-
mid was used for template and the 5’GCGGATCCTCA-
GATCACTCAACGACC (forward) and the 5’GCTCTA
GAGACCGTCTGACTTCTGGAG (reverse) for G21-507
or the 5’ GCTCTAGATGATGGCCAAAGACTCCAG
(reverse) for G21-465 were used for primers. For direc-
tional subcloning, sense and antisense primers included
BamHI/XbaI (underlined) restriction sites, respectively
[21]. The PCR reaction was carried out by a denaturation
step at 95°C for 5 min, followed by 30 cycles of amplifica-
tion (94°C for 20 s, 52°C for 30 s, 72°C for 1 min) and an
extension at 72°C for 10 min.
Subcloning of the amplified DNA was done in frame
with the insect signal sequence derived from honey bee
melittin into the multiple cloning site of the pFastMelB2
plasmid baculovirus transfer vector (derived from the
pFastBac1™ of Invitrogen). The subcloned amplified
DNA was flanked by 2 Tn7 transposon donor sites (Tn7
flanked genes). The pFastMelB2 plasmid also contained an
ampicilin resistance gene and a poly histidine (polyHis)
coding sequence of 8 amino acids added to the carboxy
end (5’ TCTAGACATCACCACCACCATCACTAA) of
the recombinant gene protein. The recombinant pFast-
MelB2 constructs were transfected into DH5a E.coli and
ampicilin-resistant clones were isolated following standard
methods.
Recombinant baculoviruses were then constructed
using the Bac-to-Bac
® baculovirus expression system
(Invitrogen) and following the manufacturer’si n s t r u c -
tions. The Bac-to-Bac site-specific transposition system
uses the DH10 Bac™strain of E. Coli, which contains a
Tn7 helper plasmid to insert exogenous Tn7-flanked
genes into the Tn7 target site of its 150-kb bacmid DNA.
Briefly, the pFastMelB2 recombinant constructs contain-
ing the Tn7-flanked G21-507 or G21-465 sequences were
first transfected into DH10 Bac™-competent E. coli cells.
Transformed colonies were then identified by antibiotic
selection and blue/white screening (since Tn7 transposi-
tion disrupts lacZa). High molecular weight DNAs con-
taining the recombinant bacmids were then prepared
from selected E. coli clones.
Next, recombinant baculoviruses were produced in Spo-
doptera frugiperda (Sf21) insect cells (Invitrogen, Barce-
lona, Spain). Thus, Sf21 cells cultured in Grace’si n s e c t
media (Gibco BRL) with 10% foetal bovine serum, 3%
non-essential amino acids and 20 μg/ml gentamicin at 28°
C [22] were co-transfected with the recombinant bacmids
and wild-type AcMNPV baculovirus using lipofectamine
®
(Gibco BRL). Seventy two hours after transfection, super-
natants containing the recombinant baculoviruses were
collected and amplified by re-infecting fresh Sf21 insect
cells. As a negative control, the wild-type baculovirus with
no insert (BacNi) was used.
Trichoplusia ni (cabbage looper) larvae [18-20] were
bred as previously described [22,23] and used to grow the
recombinant baculoviruses. Briefly, Trichoplusia ni eggs
were placed in larvae developmental cages at 22°C, 50%
humidity, under a 8 h/day-light period and fed an insect
diet [24] for 10-14 days. Instar larvae were sedated for
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with 10 μlo f~3 0×1 0
6 pfu/ml of the corresponding
recombinant baculoviruses with the aid of a semi-auto-
matic injector. Larvae injected with BacNi baculovirus
were used as a negative control. Inoculated larvae were
maintained at 28°C, and 72 h later, when they became
swollen, pale and lethargic, they were frozen immediately
at -70°C until processing.
Using immunoblotting to detect specific gpG epitopes
in the G21-507 and G21-465 sequences derived from
insect, 30 μg of insect protein extract per lane was
loaded in 12% SDS-polyacrylamide gels, separated, and
then transferred to nitrocellulose membranes (Schleicher
& Schuell). These membranes were first treated over-
night with a blocking solution of phosphate buffer sal-
ine-0.05% Tween 20 (PBS-T) with 4% skin milk. They
were then cut in 2 parts contining 4 lanes each and
each part was incubated for 1 h at room temperature
with an anti-poly His MAb (Sigma) or with 50-fold
diluted anti-G MAb mixture (see below). After washing
with PBS-T, lanes were incubated with 200-fold diluted
anti-mouse horseradish peroxidase-conjugated IgGs
(Sigma). Finally, the bands were visualized by chemilu-
miniscence with an ECL kit (Amersham) (Figure 1).
The anti-VHSV gpG-specific monoclonal antibodies
(MAbs) C10 [25,26], I16 (INRA, unpublished), 3F1A12
and IPIH3 (unpublished) were obtained from the French
INRA (Dr. M. Bremont) and the Denmark Centre of
Aarhus (Dr. N. Lorenzen), respectively. At least 500 ml
of hybridoma culture supernatants was purified by affi-
nity chromatography on protein A to 1 mg/ml of IgG.
An equimolar mixture of purified C10, I16 and 3F1A12
was used to detect VHSV gpG in the immunoblots.
To obtain purified recombinant polyhistidine-tagged
proteins by Ni2+ affinity chromatography, 50 recombi-
nant baculovirus-infected larvae (~15 g) were homoge-
nized in 6 M guanidinimun chloride, 1 M sodium
chloride in 40 mM phosphate buffer at pH 7.8 contain-
ing 25 mM imidazole and a protease inhibitor cocktail
(Complete, Roche). The extracts were then homogenized
at 10 W with a needle Virtis sonicator until a clear
lysate was obtained. After removing the pellet by centri-
fugation at 10000 g for 10 min, the supernatants were
filtered through Miracloth paper to remove the lipidic
fraction (Calbiochem). A 3-ml bed Probond (Invitrogen)
column was used to retain the polyhistidine-containing
recombinant proteins. Bound proteins were then eluted
using the same buffer with 250 mM imidazole. To maxi-
mize yields, fractions with absorbances > 0.3 at 280 nm
(Figure 2: fractions 3, 4, 5, 6 and 7 for G21-507 and 3,
4, 5, 6, 7 and 8 for G21.465) were pooled. To prevent
their precipitation, these fractions were immediately
adjusted to pH 4, chromatographed through a Sephadex
G-100 column in 20 mM sodium acetate pH 4 and
extensively dialyzed against 20 mM sodium acetate pH
4. Protein concentrations were determined using the
bicinchoninic acid (BCA) method [27] and purity was
confirmed by densitometry of Coomassie-blue stained
protein bands separated on 10-20% polyacrylamide gra-
dient gels (PAGE, BioRad). The purified recombinant
proteins were kept frozen until use.
To estimate the binding of MAbs and trout anti-VHSV
gpG Abs to purified G21-465, each well in 96-well Maxi-
Sorb polystyrene plates (Nunc) was coated with 2 μgo f
the native or reduced ß-mercaptoethanol purified recom-
binant G21-465 in 100 μl of carbonate buffer pH 9.6
overnight at 4°C [10]. To reduce the disulphide bonds of
G21-465, 200 μgo fp r o t e i ni n2 0 0μLo fH 2Ow a si n c u -
bated with 120 mM ß-mercaptoethanol for 2 min at 100°
C. Forty μl of 500 mM iodoacetamide were then added in
0.1 M sodium bicarbonate and the mixture was incubated
for 30 min at 37°C. The final mixture was dialyzed against
20 mM sodium acetate pH 4. The coated wells were then
blocked for 1 h with 100 μl/well of dilution buffer (0.5%
bovine serum albumin, 0.1% Tween 20, 0.01% merthiolate,
0.005% phenol red in phosphate buffered saline pH 6.7 or
7.7) and washed with 0.05% Tween 20 immediately before
performing the ELISA. The wells were incubated with
100 μl/well of MAbs or trout sera diluted to 2.5 μg/well or
200-fold in dilution buffer, respectively, for 60 min at
room temperature. After washing, they were incubated for
30 min with anti-trout immunoglobulin MAb 1G7 [28]
and anti-mouse horseradish peroxidase-conjugated IgGs
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Figure 1 Recognition of extract proteins from Trichoplusia ni
insect larvae infected with recombinant baculoviruses BacNi
(lanes A and E), G21-465 (lanes B and F), G21-507 (lanes C and
G) and concentrated VHSV (lanes D and H) with anti polyHis
(lanes A, B, C, D) or anti-gpG (lanes E, F, G, H) MAbs. Larvae
were collected 72 hours after infection with the recombinant
baculoviruses. Larvae were homogenized in guanidinium-free buffer
and their soluble proteins were extracted. Thirty μg of protein
extracts was loaded and electrophoresed in the same 12%
polyacrylamide gel (PAGE) and transferred to a nitrocellulose
membrane. The membrane was then cut and reacted with anti-His
MAb (lanes A, B, C and D) or with anti-gpG MAb mix (lanes E, F, G
and H) and peroxidase labelled anti-mouse Ig and then detected by
chemiluminiscence. Some of the molecular weight markers on KDa
are shown by the arrow numbers to the left and to the right.
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Page 3 of 7(Sigma) and developed with o-phenylenediamine, as
described before [29].
VHSV 07.71 was grown in epithelial papullosum
cyprini (EPC) cells and concentrated from infected EPC
supernatants by using 7% polyethylene glycol (PEG)
6000 in 2.3% NaCl, pH 7.8, as described previously [7,8].
Sera from VHSV-immunized rainbow trout (Oncor-
ynchus mykiss) were used to study the pH-dependent
recognition of the purified G21-465 by fish Abs. Thus,
hyperimmunized sera from 3 rainbow trout (hyperim-
munized rainbow trout sera, hTS) intraperitoneally
injected with 30 μg of purified VHSV 07.71 were
obtained as described before [9], by following the
experimental protocols approved by the corresponding
Ethics Committee of the Departamento de Biotecnologia
(INIA). Sera from VHSV 07.71-infected trout survivors
with their corresponding neutralization titers (50% pla-
que neutralization tests, PNT) were gifts from Dr. Cas-
tric (AFSSA, France). Pool1 corresponded to the 3 hTS,
pool 2 corresponded to 3 sera from VHSV-infected
trout with non-detectable (< 40) neutralization titers,
while pool 3 corresponded to sera from 4 VHSV-
infected trout with neutralization titers > 5120.
Results
The corresponding gpG gene sequence between amino
acids 21-507 (complete gpG) was first cloned into the
pFastMelB2 plasmid. The recombinant G21-507 gene
under the control of the polyhedrin promoter, using an
insect signal sequence derived from honey bee melitin
and adding a carboxy terminal poly histidine (polyHis)
tag for affinity purification, was included in recombinant
baculoviruses. However, preliminary results showed that
G21-507 was expressed in low yields when the corre-
sponding recombinant baculovirus was injected into
insect larvae, it precipitated out of solution when puri-
fied, and it was not stable after freezing. The alternative
G21-465 sequence, devoid of their transmembrane and
carboxy-terminal domains, was then designed, cloned
and expressed in baculovirus.
To identify recombinant gpG protein expression, spe-
cificity was confirmed by immunoblotting using com-
mercial anti-polyHis MAb and an anti-G MAbs mixture
(C10, I16 and 3F1A12) (Figure 1). In most preparation
batches (n = 5), electrophoresed and immunoblotted
protein extracts from insect larvae injected with G21-
465 recombinant baculovirus showed 3-4 unresolved
individual bands between 44 to 56 KDa which were
similar with both MAbs (Figure 1 lanes B and F, respec-
tively). Those injected with G21-507 showed 2-3 unre-
solved individual bands between 44 to 46 KDa with
anti-polyHis MAb or 44 to 56 KDa with anti-G MAbs
mixture (Figure 1 lanes C and G, respectively). Native
G1-507 obtained from concentrated VHSV, showed
either no bands with anti-polyHis MAb and 2-3 unre-
solved individual bands between 50 to 58 KDa when
reacted with the anti-G MAbs mixture (Figure 1 lanes D
and H, respectively). No major immune-reactive bands
in the 32-60 KDa region were detected in the extracts
from insect larvae injected with the BacNi baculovirus
(Figure 1 lanes A and E). The corresponding theoretical
molecular weights of the amino acid backbone
sequences corresponding to the recombinant G21-465
and G21-507 without any modification (glycosilation)
and including the polyHis tails were 51.499 and 55.868
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Figure 2 Ni-affinity chromatography fractions of protein
extracts from Trichoplusia ni insect larvae infected with
recombinant baculoviruses, and PAGE of the pooled fractions
of G21-465 (insert). Fifty recombinant baculovirus-infected larvae
(~10 g) were homogenized in 6 M guanidinimun chloride, 1 M
sodium chloride in 40 mM phosphate buffer at pH 7.8 containing
25 mM imidazole. They were then disrupted by sonication and
centrifuged until a clear lysate was obtained. A 3-ml Probond
(Invitrogen) bed column was used to retain the polyhistidine-
tagged recombinant proteins. Bound proteins were eluted using the
same buffer with 250 mM imidazole. ●, protein extract from larvae
infected with the G21-465 recombinant baculovirus. ■, protein
extract from larvae infected with the G21-507 recombinant
baculovirus. *, protein extract from larvae infected with the BacNi
baculovirus. Fractions with an absorbance > 0.3 at 280 nm were
pooled and electrophoresed in a 4 to 20% polyacrylamide gel.
Results of G21-465 stained with Coomassie-blue are shown in the
insert.
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Page 4 of 7Da (54.814 Da of the viral G21-507 plus 1054 Da of the
polyHys tail), respectively. The small differences and/or
the variety of apparent molecular weights displayed in
the immunoblotting bands could be explained by dis-
tinct glycosylation patterns. Alternatively, minor immu-
noreactive bands with lower molecular weights could
also be derived from proteolytic cleavages of the main
protein bands.
Figure 2 shows the absorbance profiles obtained by Ni2+
affinity chromatography purification of protein extracts
from G21-465, G21-507 and BacNi baculovirus-injected
insect larvae in 6 M guanidinimun chloride and 1 M
sodium chloride (denaturing buffer). The amount of puri-
fied G21-465 was 4-5-fold higher than the amount of
G21-507. We estimated the amount of insect larvae pro-
teins in the BacNi control to be 6- to 7- and 4- to-5-fold
lower than G21-465 and G21-507 proteins, respectively.
The G21-465 purified protein migrated as 4 main bands in
gradient polyacrylamide PAGE with apparent molecular
weights of 57, 55.5, 50.5 and 47 KDa (insert of Figure 2).
Further purification by sephadex chromatography reduced
the amounts of the smaller molecular weight bands (not
shown). Upon frozen storage, G21-507 precipitated out of
solution and could not be redisolved using non-denaturing
buffers. In contrast, we were able to freeze and thaw the
G21-465 sequence several times without it precipitating
out of solution. Given the instability shown by G21-507,
we selected G21-465 to continue with characterization
studies. Thus, further preparative experiments after affinity
and sephadex chromatography yielded 15 mg of purified
G21-465 (an estimated mean of 0.3 mg per larvae, n = 50)
with > 85% of purity. Parallel purifications using non-
denaturing buffers (buffers in the absence of guanidinimun
and sodium chlorides) for the affinity chromatography
resulted in very low yields of G21-507 and G21-465.
Although the G21-465 expression product was in a
disulphide-intact conformation, it could also be partially
denatured after affinity purification in the presence of
high concentrations of guanidinium. Therefore, we
applied ELISA to study the recognition of G21-465 by
conformation-dependent/-independent MAbs at both
physiological (7.7) and fusion (6.7) pHs. Because the
wild-type gpG has 8 disulphide bonds [25], in order to
estimate the disulphide conformation dependence of the
MAb binding, we also estimated binding in the presence
and absence of ß-mercaptoethanol. Given that earlier
observations showed a higher immunoblotting reactivity
between sera from VHSV-immunized trout and recom-
binant fragments of gpG (not published), we also exam-
ined the binding of sera from VHSV-immunized trout
at a range of pHs.
Solid-phase immobilized G21-465 was recognized by
anti-gpG MAbs 3F1A12, C10, I16 and IPIH3 and by
sera from trout hyperimmunized with VHSV (Figure 3).
Reduction of the disulphide bonds of G21-465 decreased
their recognition by 3F1A12 and C10 8- and 2-fold,
respectively, while the binding of MAbs I16 and IP1H3
remained unchanged. The 3F1A12 MAb epitopes
mapped to position 253 (N. Lorenzen, personal commu-
nication), a position flanked by 2 close cystein residues
forming a disulphide bridge [25], while the C10 MAb
epitopes mapped simultaneously to 2 separated amino
acid positions in the gpG sequence: 140 and 433 [26].
Therefore, it was expected that 3F1A12 and C10 binding
would be affected by ß-mercaptoethanol treatment. In
contrast, I16 and IPIH3, which were insensitive to this
treatment, mapped at lineal epitopes located at amino
acid positions 139-153 and 399-413, respectively [9].
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Figure 3 Recognition of solid-phase G21-465 by anti-gpG
MAbs and VHSV-hyperimmunized trout sera (hTS). Plates were
coated with 1 μg per well of insect-derived G21-465 untreated (- ß)
or treated with ß-mercaptoethanol (+ ß), as indicated in the text.
Hyperimmunized trout sera (hTS) were obtained by intraperitoneal
injections of purified VHSV and diluted 2000-fold. The MAb 2C9 was
an anti-VHSV nucleocapsid N-MAb used as a negative control [29].
MAbs were used at 2.5 μg per well. Open bars, ELISA performed
with dilution buffer adjusted to pH 6.7. Black bars, ELISA performed
with dilution buffer adjusted to pH 7.7. Means and standard
deviations from 4 experiments are shown.
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dependent functional activity was preserved in the G21-
465 recombinant protein. This finding is most probably
attributable to slow refolding during sephadex chroma-
tography and dialysis, since G21-465 precipitated when
these steps were omitted or performed at physiological
pH.
Similar MAb binding profiles were obtained when the
ELISAs were done using dilution buffer at pH 6.7
(fusion) and 7.7 (physiological)(Figure 3), except for
C10, which showed lower binding at pH 6.7. In contrast,
the binding of sera from hyperimmunized rainbow trout
(hTS) to G21-465 by ELISA (Figure 3) or of several
immunized trout sera by immunoblot blot (Table 1) at
pH 6.7 were 2-3-fold higher than binding at pH 7.7.
Results were similar with pooled hyperimmunized trout
sera (trout intraperitoneally injected with purified
VHSV) and with pooled trout sera surviving VHSV
infection with undetectable neutralization titers (< 40)
or with high neutralization titers (> 5120). Given that
the conformational changes at pH 6.7 affect many epi-
topes of gpG [8,20], these results were also expected
when using polyclonal Abs such as those from immu-
nized trout sera. Previous immunoblotting to detect
anti-G Abs in VHSV-survivor trout sera has been per-
formed at alkaline pHs [30,31], thus their reduced reac-
tivity under these conditions might explain the failures
to detect anti-G Abs by immunoblotting in some sera
from VHSV-immunized trout [30,31].
The production of G21-465 in insect larvae and their
down-stream purification were straightforward proce-
dures and did not require disruption of the native disul-
phide structure of the protein. In contrast, for the
isolation in soluble form of a yeast-derived recombinant
gpG (G4) [11], unfolding by high temperature in the
presence of elevated concentrations of ß-mercaptoetha-
nol were required. Previous purification of recombinant
frg11 (amino acid 56-110) designed from the fusion-
related domain of VHSV gpG [20,32,33] showed its
potential application for ELISA [10], a possibility which
was recently confirmed by further studies [34]. From the
practical point of view, the production of recombinant
gpG in insect larvae was as reproducible as recombinant
frg11 in E. coli [10], with the added advantage that most
of the gpG epitopes, including the disulphide-dependent
epitopes, were conserved only in the insect system. We
propose that the conservation of most of the gpG disul-
phide structure will allow new applications for this
recombinant protein, among these use for the detection
of disulphide-dependent conformational epitopes. The
presence of a samll histidine tag in the G21-465 mole-
cule is not expected to interfere with ELISA, as this has
not been reported for other recombinant proteins
obtained in this system [21-23].
To be used for solid-phase in ELISA, purified VHSV [7],
purified gpG from VHSV [7] or recombinant unfolded
yeast G4 protein [8-10], met with difficulties, mainly as a
result of their low yields and tendency to precipitate.
Given that the G21-465 sequence obtained by using the
purification procedure described here it is expected to
maintain all its disulphide-dependent [25] epitopes, both
in the pre-fusion and post-fusion conformations [2,3] and
it can be obtained in large amounts in soluble form, it
might be suitable for antigenicity studies and for the devel-
opment of detection methods for fish anti-gpG Abs.
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Table 1 pH-dependence of the recognition of G21-465 by sera from hyperimmunized (pool 1) and VHSV-infected (pool
2 and pool 3) rainbow trout as shown by immunoblotting
Trout sera Immunization with VHSV-07.71 Number of sera Neutralization titer pH 6.7/pH 7.7, ratio
Pool 1 Hyperimmunized 3 800 2.85 ± 1.36 (n = 3)
Pool 2 Surviving infection 3 < 40 3.45 ± 0.23 (n = 2)
Pool 3 Surviving infection 4 > 5120 3.12 ± 0.58 (n = 2)
G21-465 was electrophoresed in 5-20% polyacrylamide gels (gradient PAGE), transferred to nitrocellulose and derived strips were used for reaction with each of
the pooled trout sera at pH 6.7 and 7.7 as described, except that diaminobenzidine (DAB) was used for staining the reaction. Pool 1 included 3 sera from trout
hyperimmunized by injection of purified VHSV with neutralization titers of 800 (dilution of the sera causing a 50% decrease in the in vitro VHSV titer). Pool 2
included 3 sera from trout surviving infection with VHSV with neutralization titers < 40 (gift of Dr.Castric). Pool 3 included 4 sera from trout surviving infection
with VHSV with neutralization titers > 5120 (gift from Dr. Castric). The intensity of the stained bands were estimated by densitometry (Image J 1.38x, http://rsb.
info.nih.gov/ij) and ratios were then calculated by the formula: intensity of the stained bands at 6.7/intensity of the stained bands at pH 7.7. Means and standard
deviations were calculated from at least 2 experiments (n).
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